Cleary’s Pharma Bites: FDI in Pharma, Biotech, and Healthcare
January 2, 2023
January 2, 2023
Cleary Gottlieb’s Pharmaceutical, Biotech, and Healthcare group is pleased to present the latest installment of its “Pharma Bites” series: FDI in Pharma, Biotech, and Healthcare.
FDI Trends
To learn more about this topic and view the related slide deck, click here.
Cleary’s Pharma Bites series seeks to provide critical updates on a wide range of antitrust, regulatory, arbitration, and litigation issues in the pharmaceutical and biotechnology space.
To learn more about Cleary’s Pharmaceuticals and Biotechnology practice, click here.